Campion Asset Management Eli Lilly & CO Transaction History

Campion Asset Management

$136 Million
Q3 2024

A detailed history of Campion Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Campion Asset Management holds 3,340 shares of LLY stock, worth $2.56 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares

3,340

Previous 3,365 0.74%

Holding current value

$2.56 Million

Previous $3.05 Million 2.86%

% of portfolio

2.18%

Previous 2.41%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $19,303 - $24,000	-25 Reduced 0.74%	3,340 $2.96 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $5,922 - $7,922	-10 Reduced 0.3%	3,365 $2.62 Million
Q2 2023 Aug 03, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 2.88%	3,375 $1.58 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $7,765 - $9,120	-25 Reduced 0.71%	3,475 $1.19 Million
Q4 2022 Mar 22, 2023	SELL	$321.55 - $374.67 $96,465 - $112,401	-300 Reduced 7.89%	3,500 $1.28 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $4,447 - $5,068	-15 Reduced 0.39%	3,800 $1.23 Million
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $6,968 - $8,181	-25 Reduced 0.65%	3,815 $1.24 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $29,336 - $36,457	-125 Reduced 3.15%	3,840 $1.1 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $5,540 - $6,817	-25 Reduced 0.63%	3,965 $916,000
Q2 2021 Jul 23, 2021	SELL	$180.55 - $233.54 $323,184 - $418,036	-1,790 Reduced 30.97%	3,990 $916,000
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $949,769 - $1.23 Million	5,780 New	5,780 $1.08 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campion Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Campion Asset Management with notifications on news.

Account

Campion Asset Management Eli Lilly & CO Transaction History